Crinetics Pharmaceuticals In shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Crinetics Pharmaceuticals In
Tip: Access up to 7 years of quarterly data
All positions including Crinetics Pharmaceuticals In held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crinetics Pharmaceuticals In by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $3.3M | 93k | 35.58 |
| 2023-09-30 | $1.6M | 54k | 29.74 |
| 2023-06-30 | $787k | 44k | 18.02 |
| 2023-03-31 | $3.0k | 200 | 15.00 |
| 2022-12-31 | $638k | 35k | 18.39 |
| 2022-06-30 | $576k | 31k | 18.66 |
| 2022-03-31 | $1.8M | 82k | 21.93 |
| 2021-12-31 | $1.4M | 48k | 28.45 |
| 2021-03-31 | $2.0M | 67k | 29.41 |
| 2020-12-31 | $1.1M | 79k | 14.11 |
| 2020-09-30 | $152k | 10k | 15.07 |
| 2020-06-30 | $160k | 9.1k | 17.47 |
| 2020-03-31 | $0 | 3.7k | 0.00 |
| 2019-12-31 | $171k | 3.8k | 45.45 |
| 2019-09-30 | $56k | 3.7k | 14.92 |
| 2019-06-30 | $75k | 3.0k | 24.73 |
| 2019-03-31 | $48k | 2.1k | 23.00 |
| 2018-12-31 | $53k | 1.8k | 29.78 |
| 2018-09-30 | $46k | 1.6k | 28.52 |